Physician profile
Jack Ju
NPI 1518455955
$842.26
in general payments reported to CMS, 2019-2025
12 companies · $144 in 2025
The $144 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $18.76 · 2020: $63.74 · 2021: $150 · 2022: $123 · 2023: $189 · 2024: $154 · 2025: $144.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $487.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $486.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $280.75 | 2021-2025 | Vaxneuvance, Gardasil 9, Rotateq |
| Supernus Pharmaceuticals, INC. | $109.28 | 2021-2022 | |
| Glaxosmithkline, LLC. | $106.67 | 2020-2024 | Bexsero |
| Cranial Technologies, INC | $94.90 | 2022-2024 | Doc Band |
| Pfizer INC. | $47.10 | 2020-2024 | |
| Takeda Pharmaceuticals U.S.A., INC. | $42.83 | 2022-2023 | |
| Neos Therapeutics, LP | $39.31 | 2019-2020 | |
| Kaleo, INC. | $30.96 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $29.27 | 2025 | Zoryve |
| Acadia Pharmaceuticals INC | $24.56 | 2023 | Daybue |
| Verrica Pharmaceuticals INC. | $22.39 | 2025 | Ycanth |
| Seqirus USA INC | $14.24 | 2025 | Flucelvax |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jack Ju listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.